A comparative pharmacokinetic evaluation of two aqueous progesterone 25 mg injections in healthy postmenopausal women under fasting conditions: An open‐label, balanced, randomized, two‐treatment, two‐period, two‐sequence, single‐dose, crossover bioequivalence study

Documents similaires

• Single‐Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non‐Pregnant, Non‐Lactating Premenopausal Female Subjects Under Fasting Conditions
  par: Sudershan Kumar, et autres
  Publié: (2026)
• Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α‐Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots
  par: Mukesh Gabhane, et autres
  Publié: (2025)
• Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations
  par: Ting Luo, et autres
  Publié: (2024)
• Bioavalaibility and pharmacokinetic comparison of two formulations of metformin 850 mg tablets in healthy Colombian volunteers
  par: GLORIA HOLGUÍN
  Publié: (2011)
• Model‐based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?
  par: Morgane Philipp, et autres
  Publié: (2024)